Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), made the following statement after Dr. Robert Califf was confirmed by the Senate to lead the Food and Drug Administration (FDA):
“We congratulate Dr. Califf on his confirmation as FDA commissioner. Dr. Califf is an excellent choice to lead the FDA at this critical juncture. He’s a proven leader whose on-the-job experience and deep understanding of the agency will allow him to hit the ground running. I have known Dr. Califf for many years. He’s effective, inclusive and makes decisions by following the science. He’s driven efforts to modernize clinical trials, including the use of real-world evidence, and he’s pushed for greater diversity in science and clinical trials. BIO looks forward to working with Dr. Califf and his leadership team on these issues and ensuring that more patients, in more communities, have access to the medical breakthroughs they need to live healthier and more productive lives.”
